The results of the mente autism device trial will be presented next week at the world autism conference in Texas, 12-15 November. NTI will have a presence there, and i can't imagine a better audience in which to garner interest in their device. I am sure the company will also be looking at potential distribution partners in the US with FDA clearance due hopefully within 6 months.
This conference may be the turning point for NTI. The fundamentals are the same as they were 2 months ago when the sp was 13 cents.
